Dietary Supplement Listing Act of 2026

# Dietary Supplement Listing Act of 2026 - Summary **What the Bill Would Do** The Dietary Supplement Listing Act of 2026 would require manufacturers of dietary supplements (vitamins, minerals, herbs, and similar products) to register and list their products with the Food and Drug Administration (FDA). Currently, dietary supplements don't need FDA approval before being sold, though manufacturers must report serious health problems to the agency. This bill would create a more formal registration system, giving the FDA advance notice of what supplements are on the market. **Who It Affects and Key Details** The bill primarily affects dietary supplement manufacturers and distributors, who would need to comply with new registration requirements.

Consumers may be indirectly affected if the requirements change product availability or pricing. The bill was introduced by Senator Richard Durbin (D-IL) but hasn't progressed beyond the committee stage, meaning it hasn't been debated or voted on by the full Senate yet. **Current Status** As of now, this bill remains "in committee," meaning it's under review and hasn't moved forward in the legislative process. There's no indication of immediate action, and it may not advance further in the current Congress.